GW Pharma (GWPH) PT Lowered to $227 at Morgan Stanley
Tweet
Share
E-mail
Get Alerts GWPH Hot Sheet
Price: $218.96 --0%
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 2
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 2
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on GW Pharma (NASDAQ: GWPH) to $227.00 (from $240.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades XP Inc. (XP) to Equalweight
- Wolfspeed (WOLF) PT Lowered to $30 at Deutsche Bank
- Piper Sandler Upgrades BlackLine (BL) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
